Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by PLITheOneon Aug 11, 2021 7:58am
35 Views
Post# 33683715

No revenue left for Liminal!

No revenue left for Liminal!
We will see how fast the money goes and to where. 
SALP? Lawsuit settlement, Long term debt, outrageous salaries and bonuses, operational costs?

Either way, this company is not sustainable as orchestrated by Thomvest. Their plan has played out as we have predicted and the share price is on a steady decline.

This sale is only a blip and the price will soon, if not today go under $3 and continue is decline down and the ultimate demise of Liminial. Thomvest has a plan, it will not stop!
<< Previous
Bullboard Posts
Next >>